Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A.
Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A. J Thromb Haemost. 2024 Jul; 22(7):1880-1893.
View in:
PubMed
subject areas
Adolescent
Adult
Coagulants
Factor VIII
Genetic Therapy
Hemophilia A
Hemorrhage
Hepatocytes
Humans
Male
Middle Aged
Quality of Life
Surveys and Questionnaires
Time Factors
Treatment Outcome
Young Adult
authors with profiles
Johnny